[1. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet .1992; 339: 572-5.10.1016/0140-6736(92)90865-Z]Search in Google Scholar
[2. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol. 2000; 20:2032-7.]Search in Google Scholar
[3. Bogatcheva NV, Garcia JG, Verin AD. Molecular mechanisms of thrombin-induced endothelial cell permeability. Biochemistry (Mosc). 2002; 67:75-84.10.1023/A:1013904231324]Search in Google Scholar
[4. Jiang DJ, Jia SJ, Dai Z, Li YJ. Asymmetric dimethylarginine induces apoptosis via p38 MAPK/ caspase-3-dependent signaling pathway in endothelial cells. J Mol Cell Cardiol. 2006; 40:529-39.10.1016/j.yjmcc.2006.01.021]Search in Google Scholar
[5. Kayyali US, Pennella CM, Trujillo C, Villa O, Gaestel M, Hassoun PM. Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J Biol Chem. 2002; 277:42596-602.10.1074/jbc.M205863200]Search in Google Scholar
[6. Borbiev T, Birukova A, Liu F, Nurmukhambetova S, Gerthoffer WT, Garcia JG, et al. p38 MAP kinasedependent regulation of endothelial cell permeability. Am J Physiol Lung Cell Mol Physiol. 2004; 287: L911-18.10.1152/ajplung.00372.2003]Search in Google Scholar
[7. Maruo N, Morita I, Shirao M, Murota S. IL-6 increases endothelial permeability in vitro. Endocrinology. 1992; 131:710-4.]Search in Google Scholar
[8. Boger RH. Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials. Vasc Med. 2005; 10 (Suppl 1):S19-25.10.1177/1358836X0501000101]Open DOISearch in Google Scholar
[9. Boger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res. 2003; 59:824-33.10.1016/S0008-6363(03)00500-5]Search in Google Scholar
[10. Ju Y, Wang T, Li Y, Xin W, Wang S, Li J. Coxsackievirus B3 affects endothelial tight junctions: possible relationship to ZO-1 and F-actin, as well as p38 MAPK activity. Cell Biol Int. 2007; 31:1207-13.10.1016/j.cellbi.2007.04.00317544707]Search in Google Scholar
[11. Toshiyuki O, Glenn EB, Michael BY. Kinase pathways activated by stress: the p38MAPK pathway. Crit Care Med. 2000; 28:66-77.]Search in Google Scholar